Following an epic global transformation, GSK’s Emerging Markets came into the spotlight with an enormous mandate that captured the “Power of Winning, Now” across 113 countries and 14000+ employees.
The newly appointed Business Head of Emerging Markets initiated an accelerated cultural change through a complete transformation starting with leadership. CorporateDNA was tasked to create a culture that stimulates growth, engagement among colleagues and pride in working for an innovative, high performing region.
This mandate was given after an intense reorganization, which signalled bold and unprecedented changes within the company. The people who were chosen not only had great experience, but had to demonstrate certain character traits that combined high confidence with high humility to drive change.
The CorporateDNA culture transformation process was used to deepen the change narrative for Emerging markets, heighten the levels of self-awareness throughout the Emerging Market Leadership and energize purpose through a shared way of working. Habit installation methods were used to ensure that the new, desired ways of working became hard wired in regular meetings, decisions, and reviews. The personalities of Emerging Markets were defined and then tested to see if the new beliefs, mindsets, and behaviours could withstand the challenges of 2020. This double loop process of co-creation, adjustment and reinforcement allowed the new culture to embed through a shared language, feedback loops and hard metrics, while reducing blame, denial, and avoidance.